EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,821 | -1.0% | 20,985 | +30.2% | 0.00% | – |
| Q4 2022 | $19,012 | -84.3% | 16,112 | 0.0% | 0.00% | – |
| Q3 2022 | $121,323 | +18.9% | 16,112 | 0.0% | 0.00% | – |
| Q2 2022 | $102,000 | -8.1% | 16,112 | +20.4% | 0.00% | – |
| Q1 2022 | $111,000 | +60.9% | 13,380 | 0.0% | 0.00% | – |
| Q4 2021 | $69,000 | -25.8% | 13,380 | -3.6% | 0.00% | – |
| Q3 2021 | $93,000 | -21.2% | 13,875 | 0.0% | 0.00% | – |
| Q2 2021 | $118,000 | -4.1% | 13,875 | 0.0% | 0.00% | – |
| Q1 2021 | $123,000 | -59.3% | 13,875 | -43.5% | 0.00% | -100.0% |
| Q4 2020 | $302,000 | +102.7% | 24,546 | +33.7% | 0.00% | – |
| Q3 2020 | $149,000 | +93.5% | 18,365 | +62.6% | 0.00% | – |
| Q1 2020 | $77,000 | -54.2% | 11,297 | 0.0% | 0.00% | – |
| Q4 2019 | $168,000 | – | 11,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |